mk 0591 has been researched along with Bone Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ghosh, J; Ghosh, R; Morisetty, S; Sarveswaran, S | 1 |
1 other study(ies) available for mk 0591 and Bone Cancer
| Article | Year |
|---|---|
MK591, a second generation leukotriene biosynthesis inhibitor, prevents invasion and induces apoptosis in the bone-invading C4-2B human prostate cancer cells: implications for the treatment of castration-resistant, bone-metastatic prostate cancer.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Humans; Indoles; Leukotriene Antagonists; Male; Neoplasm Invasiveness; Neoplasm Metastasis; Prostate; Prostatic Neoplasms, Castration-Resistant; Proto-Oncogene Proteins c-akt; Quinolines; Signal Transduction | 2015 |